Back to mobile site

TD Cowen Starts Tonix Pharma (TNXP) at Buy

May 4, 2026 5:30 AM EDT Send to a Friend
TD Cowen analyst Stacy Ku initiates coverage on Tonix Pharma (NASDAQ: TNXP) with a Buy rating and a price target ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login